Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Severe Obesity

Night eating syndrome among adults with obesity attending a tier 3 weight management service

C. Breen; K. Gaynor; A. Villiers Tuthill; L. Devereux; N. Wallace; C. Dunlevy; E. O'Malley; J. Mehegan; J. Meurling; J. O'Connell; D. O'Shea Night eating syndrome among adults with obesity attending a tier 3 weight management service 26th European Congress on Obesity

The Association of Physical Function Measures With Frailty, Falls History, and Metabolic Syndrome in a Population With Complex Obesity

A. Rhynehart; C. Dunlevy; K. Hayes; J. O'Connell; D. O'Shea; E. O'Malley The Association of Physical Function Measures With Frailty, Falls History, and Metabolic Syndrome in a Population With Complex Obesity Frontiers in Rehabilitation Sciences
Metabolic Syndrome

Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial

V. Mocanu; Z. Zhang; E. C. Deehan; D. H. Kao; N. Hotte; S. Karmali; D. W. Birch; K. K. Samarasinghe; J. Walter; K. L. Madsen Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial Nat Med
Insulin Resistance & Diabetes Metabolic Syndrome

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

X. Pi-Sunyer; A. Astrup; K. Fujioka; F. Greenway; A. Halpern; M. Krempf; D. C. Lau; C. W. le Roux; R. Violante Ortiz; C. B. Jensen; J. P. Wilding A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management N Engl J Med

Weight loss outcomes with semaglutide 2.4 mg in moderate or severe obesity in step 1 and 2

C. Le Roux; A. Aminian; R. Batterham; D. Hesse; C. Jensen; B. McGowan; A. Pakseresht; G. Rigas Sydney; F. Rubino; S. Taheri; et al. Weight loss outcomes with semaglutide 2.4 mg in moderate or severe obesity in step 1 and 2 Obesity (Silver Spring, Md.)
Insulin Resistance & Diabetes

Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial

E. C. Deehan; E. Colin-Ramirez; L. Triador; K. L. Madsen; C. M. Prado; C. J. Field; G. D. C. Ball; Q. Tan; C. Orsso; I. Dinu; M. Pakseresht; D. Rubin; A. M. Sharma; H. Tun; J. Walter; C. B. Newgard; M. Freemark; E. Wine; A. M. Haqq Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial Trials
Insulin Resistance & Diabetes

Miscarriage after sonographic confirmation of an ongoing pregnancy in women with moderate and severe obesity

V. O'Dwyer; B. Monaghan; C. Fattah; N. Farah; M. M. Kennelly; M. J. Turner Miscarriage after sonographic confirmation of an ongoing pregnancy in women with moderate and severe obesity Obes Facts

Timing of screening for gestational diabetes mellitus in women with moderate and severe obesity

V. O'Dwyer; N. Farah; J. Hogan; N. O'Connor; M. M. Kennelly; M. J. Turner Timing of screening for gestational diabetes mellitus in women with moderate and severe obesity Acta Obstet Gynecol Scand
Insulin Resistance & Diabetes

The clinical outcomes of unplanned pregnancy in severely obese women

A. McKeating; P. J. Maguire; M. Farren; N. Daly; S. R. Sheehan; M. J. Turner The clinical outcomes of unplanned pregnancy in severely obese women J Matern Fetal Neonatal Med

Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women

S. K. Ismail; L. Norris; S. O'Shea; J. R. Higgins Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women Thromb Res

Older posts

Newer posts

← Previous Page1 … Page5 Page6 Page7 … Page9 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI